FEATURED
Roche Advances Novel Antibiotic Targeting Superbug into Phase 3 Trials
Swiss pharmaceutical company Roche has announced plans to advance its experimental antibiotic, zosurabalpin, into Phase 3 clinical trials. Developed in
DEALS
Sanofi Acquires Blueprint in $9.1B Deal to Bolster Rare Immunological Disease Pipeline
Sanofi has announced a definitive agreement to acquire Blueprint Medicines, a U.S.-based biopharmaceutical company focused on systemic mastocytosis (SM) and
PRESS RELEASES
Striatech Debuts New Non-Aversive Animal Platform
Striatech, a leader in preclinical vision research devices and tools, has unveiled its New Non-Aversive Animal Platform for the OptoDrum
EDITOR’S PICKS
The Growing Importance of RNA Sequencing in Drug Discovery
Advanced single-cell technologies, particularly methods such as single-cell RNA sequencing (scRNA-seq), coupled with sophisticated computational tools and the increasing accessibility
RESOURCES
Enhancing the Accuracy of Plasma Protein Binding Assays
Enhancing the Accuracy of Plasma Protein Binding (PPB) Assays for Challenging Drug Candidates An Inotiv Case Study Evaluating Sovicell’s TRANSIL
MANUFACTURING PROJECTS
AstraZeneca Unveils $300 Million Cell Therapy Manufacturing Facility in Rockville, USA
Global biopharmaceutical leader AstraZeneca has officially opened a new $300 million state-of-the-art cell therapy manufacturing facility in Rockville, Maryland, marking
CLINICAL TRIALS
Roche Advances Novel Antibiotic Targeting Superbug into Phase 3 Trials
Swiss pharmaceutical company Roche has announced plans to advance its experimental antibiotic, zosurabalpin, into Phase 3 clinical trials. Developed in
REGULATORY
Novartis Secures Landmark FDA Approval for Fabhalta® in Rare Kidney Disease
Novartis has received its third U.S. Food and Drug Administration (FDA) approval for Fabhalta® (iptacopan), marking a major milestone as
SELECTED PRODUCTS
In Vivo Assessment of Visual Performance in Mice
The unique OptoDrum device for automated in vivo assessment of visual performance in mice and rats offers unmatched capabilities for
